Zeolita

Zeolite (Clinoptilolite): A Comprehensive Reference

1. Identity, Chemical Nature, and Natural Sources

Zeolites are a family of naturally occurring and synthetic microporous, crystalline, hydrated aluminosilicates. They are hydrated aluminosilicates of the alkaline and alkaline-earth metals; about 40 natural zeolite species have been identified over the past 200 years, the most common of which include analcime, chabazite, clinoptilolite, erionite, ferrierite, heulandite, laumontite, mordenite, and phillipsite. More than 150 zeolites have been synthesized; the most common are zeolites A, X, Y, and ZSM-5.

In the context of dietary supplementation and human medicine, the term "zeolite" almost invariably refers to clinoptilolite, a naturally occurring high-silica zeolite. It belongs to a family of over 40 natural zeolite minerals, but clinoptilolite is by far the most commercially used because of its stability, abundance, and well-studied ion-exchange properties. Clinoptilolite is a geological term used to describe one of the naturally occurring, high silica content zeolites.

Chemical Formula and Structure

Clinoptilolite's typical chemical formula is (Na₂,K₂,Ca)₃Al₆Si₃₀O₇₂·24H₂O, though the exact composition shifts depending on where it is mined. The outer framework is built from tiny tetrahedra of silica and alumina locked together in a rigid, three-dimensional cage, and inside those cages sit water molecules and loosely held ions of calcium, potassium, and sodium. Zeolites are natural, hydrated, crystalline aluminosilicates composed of SiO₄ and AlO₄ linked together by oxygen atoms into three-dimensional frameworks, like a honeycomb structure with microspores. A negative framework charge caused by the presence of aluminium is balanced by the required number of cations to make it neutral. These cations are not part of the zeolite network and can be replaced by other cations.

An empirical chemical oxide composition for a representative clinoptilolite-rich material has been reported as: SiO₂ 68.3%, Al₂O₃ 12.8%, Fe₂O₃ 1.1%, CaO 3.2%, MgO 0.7%, K₂O 3.4%, Na₂O 1.0%, and loss on ignition (LOI) 8.5%, with a cation exchange capacity of 160 mEq/100 g.

Geological Origin and Mining

Natural zeolites form where volcanic rocks and ash layers react with alkaline groundwater. Zeolites also crystallized in post-depositional environments over periods ranging from thousands to millions of years in shallow marine basins. This material is indeed a volcanic tuff, characterized by high thermal stability and resistance to chemical substances, and in vivo applications rely on its physicochemical properties. Naturally occurring zeolites are usually found as mixtures with other minerals, metals, quartz, or other zeolites. Conventional open-pit mining techniques are used to mine natural zeolites: the overburden is removed to allow access to the ore, which may be blasted or stripped for processing by tractors equipped with ripper blades; in processing, the ore is crushed, dried, and milled, and the milled ore may be air-classified as to particle size.

2. Common Forms and Preparations

Raw clinoptilolite is typically milled into a fine powder as the starting material for all supplemental forms. Several processing technologies have been developed to enhance its physicochemical activity:

• Tribomechanically Activated Zeolite (TMAZ): TMAZ is a natural zeolite clinoptilolite with enhanced physicochemical properties and is the basis of the dietary supplements Megamin and Lycopenomin, which have demonstrated antioxidant activity in humans. The tribomechanical activation process micronizes the raw volcanic mineral into very fine particles, substantially increasing surface area.
• Panaceo Micro-Activated (PMA) Zeolite: The clinoptilolite material PMA-zeolite is provided by Panaceo International GmbH, Austria. PMA-zeolite is a certified European medical device subjected to required toxicology tests performed according to OECD and ISO guidelines. Clinoptilolite is a highly porous natural mineral with a capacity to eliminate metals from living organisms mainly by ion-exchange and adsorption. The in vivo efficiency and safety of both TMAZ and PMA zeolite forms have been examined in oral administration studies.
• Micronized clinoptilolite powder: Finely ground raw clinoptilolite, sometimes designated as ultrafine (particle sizes below 2 µm). Particle size reduction is considered relevant because smaller particles expose more internal cage surfaces.
• Capsules: Encapsulated powdered clinoptilolite, sold as dietary supplements.
• Liquid / suspension forms: Aqueous suspensions or hydrolyzed clinoptilolite fragment solutions, sold under various brand names.

Zeolite supplements come as powders, capsules, gummies, liquids, and creams. Natural zeolite deposits can contain trace amounts of the very heavy metals the product is supposed to remove. Some manufacturers use additional purification steps (the "PMA" designation in clinical trials refers to a specific activation process) to clean the zeolite's internal channels before it is sold for human consumption. Products without this kind of quality control could theoretically introduce contaminants rather than remove them.

3. Traditional and Historical Use

Zeolites are minerals with a long and significant history that originated in volcanic processes. These natural crystals formed millions of years ago when volcanic ash fell to the earth and reacted with groundwater, leading to the formation of characteristic porous structures. Zeolites have a long history, dating back to ancient times when they were used as natural minerals for various purposes such as water purification and as a drying agent. However, the systematic study of zeolites began in the mid-18th century.

Zeolite is not new to Greece. The first references to its use date back to antiquity, when Greeks harnessed the power of natural rocks for hygiene, food storage, and water purification. Zeolites continued to be used in the Middle East and Asia, particularly in traditional medicine. Arab scholars such as Avicenna described the use of zeolites in medical treatments, as found in Arabic writings from the Middle Ages. These texts indicate that zeolites were used to clean wounds and treat stomach complaints.

The term "zeolite" was formally coined in the 18th century. The term was originally coined by Swedish mineralogist Axel Fredrik Cronstedt, who found that rapid heating of a natural mineral caused the stones to dance about as the water within their pores evaporated. He combined the Greek words zein (meaning "to boil") and lithos (meaning "a stone"), to indicate a "stone that boils."

In 1845, Way discovered that certain soils retained ammonium salts. Hydrated silicates in the soil were found to be responsible, and these were probably the first ion-exchange experiments. Large tonnages of natural zeolites were not discovered until the late 1950s, when researchers reported on vast sedimentary deposits in the Western United States.

In veterinary and agricultural traditions, clinoptilolite has been widely used for many decades as a feed additive to absorb ammonia, reduce mycotoxin contamination, and improve growth in livestock. Zeolites have been used in various technological applications as molecular sieves for separating and sorting various molecules, for water and air purification, for removal of radioactive contaminants, and in biotechnology and medicine for detoxification of animal and human organisms and for improvement of nutrition status and immunity of farm animals. The antidiarrheal drug Enterex, based on purified natural clinoptilolite, was approved for human use in Cuba in the 1990s. A comprehensive study was carried out on antidiarrheal drugs based on natural clinoptilolite as an active material, in the therapy of acute diarrheal diseases in humans, which led to the approval of the antidiarrheal drug Enterex for use in humans.

4. Key Constituents and Mechanisms of Action

Unlike botanical supplements, zeolite clinoptilolite is an inorganic mineral, and its "active constituents" are not individual phytochemicals but instead the structural and ionic properties of the crystal framework itself. The primary physicochemical mechanisms that underlie observed biological effects are:

Ion Exchange

Clinoptilolite contains alkali and alkaline earth cations within its crystal framework, some of which (mainly calcium or sodium) can be easily exchanged in the environment through the ion-exchange process. This process may occur in exchange with contaminants such as lead (Pb), nickel (Ni), cadmium (Cd), or arsenic (As), due to their affinity toward the crystal framework of zeolite. The main mechanisms underlying these biological effects include incorporation of metallic ions within the zeolite clinoptilolite crystal lattice, but additional biological effects should be considered as well.

Adsorption and Molecular Sieving

Natural zeolites are crystalline aluminosilicates with unique adsorption, cation-exchange, and catalytic properties. Clinoptilolite is a zeolite with a microporous structure that enables ion exchange, molecular sieving, and adsorption, conferring detoxifying, antioxidant, and anti-inflammatory properties. The regular, uniform cage size allows clinoptilolite to act as a molecular sieve, selectively trapping molecules and ions that fit within its pore dimensions while excluding larger molecules.

Release of Bioavailable Silica

The exact biological mechanisms of action of zeolite clinoptilolite are not completely elucidated; however, obtained results point to its antioxidative, immunomodulatory and detoxifying effects, the latter partially based on release of soluble and bioavailable silica forms from the surface material.

Proposed Immunomodulatory Mechanism

A hypothesis has been proposed that M cells in the intestine, which lack a negatively charged glycocalyx unlike other intestinal cells, could absorb negatively charged clinoptilolite particles, transport them across the intestinal barrier, and present them to antigen-presenting cells in the Peyer's patches, modulating the immune response without entering the circulation.

Ammonia and Other Adsorbates

Besides metal cations and water resident in zeolites' cavities and pores, other molecules and cationic groups may be accommodated as well, such as ammonia and nitrate ions, all of which are bound to different zeolites at different affinity levels.

5. Scientific Evidence by Area of Use

5.1 Heavy Metal Detoxification

Heavy metal binding and excretion is the most studied application of clinoptilolite in humans. A total of 102 heavy-metal contaminated men were investigated and decreased concentrations of harmful metals (Cd, Pb, Cu, Cr, and Ni) were measured in their hair after a 30-day supplementation with clinoptilolite. This decrease in harmful metal concentrations was a result of the clinoptilolite detoxification function and probable restoration of body mineral metabolism homeostasis.

A series of clinical trials published in Frontiers in Medicine (2022) examined PMA-zeolite across three trials with different supplementation regimens in human subjects. A comprehensive and controlled monitoring of relevant mineral and contaminant levels in human subjects supplemented with a certified clinoptilolite material was performed within three clinical trials with different supplementation regimens. Statistically higher levels of Pb were observed in the verum groups (p < 0.001), interpreted as mobilization from body stores; in the fourth year, a statistically relevant decrease in Pb levels was observed in the PMA-zeolite-treated group compared to the third year. Aluminum (Al) and nickel (Ni) levels were statistically significantly lower in PMA-zeolite-treated patients after four years of supplementation (p < 0.001).

In several recent clinical trial studies on humans with PMA zeolite, it has been shown that preloaded metals do not enter the bloodstream from the intestine, but that observed fluctuations of metal levels in the blood are a consequence of the activation of detoxification processes from various body compartments.

Additional short-term clinical findings have also been reported: In a 12-week trial, arsenic levels dropped significantly in supplemented participants. In a short-term 28-day study, participants who started with elevated mercury and cadmium levels saw statistically significant decreases in both metals.

Evidence assessment: The human clinical evidence for heavy metal detoxification is preliminary to moderate in strength. Studies are generally small, not always placebo-controlled, and many originate from the same European research group. Preliminary evidence suggests that zeolite may help support the body's ability to detoxify and eliminate certain toxins. However, more research is needed before clinical conclusions can be made. Particularly, the complete mechanism of action of zeolite needs to be fully elucidated and more clinical studies with reproducible research outcomes are needed.

5.2 Intestinal Barrier Integrity

A study evaluated whether zeolite supplementation affects biomarkers of intestinal wall permeability and parameters of oxidation and inflammation in aerobically trained individuals. In a randomized, double-blinded, placebo-controlled trial, 52 endurance-trained men and women received 1.85 g of zeolite per day for 12 weeks. Those taking a zeolite supplement saw their zonulin concentrations drop by almost 30%, falling from above the clinical cutoff (61.2 ng/mL) into the normal reference range (43.8 ng/mL). The placebo group's levels barely changed (56.1 to 59.6 ng/mL). This is a meaningful shift because it suggests the mineral may help tighten the intestinal barrier, potentially reducing the low-grade inflammation that follows from increased gut permeability. Researchers proposed that clinoptilolite achieves this by interacting with intestinal bacteria, though the exact mechanism is still being studied.

Evidence assessment: This is a single randomized, double-blind, placebo-controlled trial in a specific population (aerobically trained adults). While the design is methodologically sound, the small sample size, specific population, and single study limit generalizability. This area warrants further independent replication.

5.3 Antioxidant Properties

TMAZ, a natural zeolite clinoptilolite with enhanced physicochemical properties, is the basis of the dietary supplements Megamin and Lycopenomin, which have demonstrated antioxidant activity in humans. Antioxidant effects in animal models are more consistently documented. In chicken, daily supplementation with natural clinoptilolite efficiently improved antioxidant capacity by increasing antioxidant enzyme activities in intestinal mucosa and decreasing free radical NO content and inducible nitric oxide synthase activity in the serum. Upon prolonged supplementation, both clinoptilolite materials increased the activities of glutathione peroxidase, catalase, total SOD, and total antioxidant capacity.

Evidence assessment: Human antioxidant evidence is limited to open-label studies and the antioxidant effects of TMAZ supplements. More robust clinical evidence in humans is lacking; most data come from in vitro and animal studies.

5.4 Immune Modulation

A prospective, open, and controlled parallel-group study investigated the effects of supplementation with TMAZ on the cellular immune system in patients undergoing treatment for immunodeficiency disorder. A total of 61 patients were administered daily TMAZ doses of 1.2 g (Lycopenomin) and 3.6 g (Megamin) for 6 to 8 weeks, during which patients' primary medical therapy was continued unchanged. Blood and lymphocyte counts were performed at baseline and at the end of the study. Animal and some human studies suggest that zeolites can stimulate the immune system. In a small study of people with a weakened immune system, a supplement containing the zeolite clinoptilolite increased the number of infection-fighting cells in their blood.

Evidence assessment: Evidence for immune modulation in humans is weak and based on open (non-blinded) studies with small populations. The study above lacked a placebo arm, limiting the interpretability of results.

5.5 Antidiarrheal Properties

The best-known positive biological activity of natural clinoptilolite is its antidiarrheal action. Clinoptilolite lowers the incidence of death and sickness from diarrheal syndrome in swine, rats, and calves. Based on these results, a comprehensive study was carried out on antidiarrheal drugs based on natural clinoptilolite as the active material in the therapy of acute diarrheal diseases in humans, and this research led to the approval of the antidiarrheal drug Enterex for use in humans. In the gut, these silicates can act as adsorbents, ion-exchangers, catalysts, detergents, or anti-diarrheal agents.

Evidence assessment: The antidiarrheal application has historical regulatory precedent in Cuba (Enterex), but peer-reviewed human clinical trial data in the primary literature remain limited. The proposed mechanisms (adsorption of pathogens and toxins in the gut) are plausible, but this remains one of the better-supported traditional indications.

5.6 Mycotoxin Adsorption

Clinoptilolite incorporated into the diet may be effective in fighting mycotoxins by direct adsorption. Affinity toward aflatoxins, zearalenone, ochratoxin, and the T-2 toxin was proven in vitro in the presence of amino acids and vitamins, where the latter were not adsorbed by the clinoptilolite material. The specificity for aflatoxin M1 was also shown in vivo, and dietary administration of clinoptilolite, especially at the smallest particle size at the rate of 200 g per cow per day, effectively reduced milk aflatoxin M1 concentration in dairy cattle. Other toxicants such as mycotoxins, aflatoxins, zearalenone, ochratoxin, lead, and organophosphate are effectively adsorbed by clinoptilolite when included in animal diets, thus reducing the morbidity associated with intoxication in livestock.

Evidence assessment: Evidence for mycotoxin adsorption is robust in animal studies and in vitro. Controlled human clinical trial data on clinoptilolite's effect on mycotoxin exposure in people are not yet established in the peer-reviewed literature.

5.7 Anticancer Research (Preclinical)

Clinoptilolite treatment of mice and dogs suffering from a variety of tumor types led to improvement in overall health status, prolongation of lifespan, and decrease in tumor size. In vitro tissue culture studies showed that finely ground clinoptilolite inhibits protein kinase B (c-Akt), induces expression of p21WAF1/CIP1 and p27KIP1 tumor suppressor proteins, and blocks cell growth in several cancer cell lines. These data indicate that clinoptilolite treatment might affect cancer growth by attenuating survival signals and inducing tumor suppressor genes in treated cells. When micronized zeolite was administered by gastric intubation to mice injected with melanoma cells, the number of melanoma metastases and the degree of lipid peroxidation decreased, possibly as a result of increased activation of macrophages and stimulants of the immune system.

A study by Pavelić et al. revealed that clinoptilolite can induce the expression of tumor-suppressive proteins, thus compromising and preventing cancer cell growth and proliferation.

Evidence assessment: Anticancer findings are entirely preclinical — based on cell culture experiments and animal models (mice, dogs). Zeolites are marketed as dietary supplements to treat cancer, but there are no published human data to support these uses. No controlled human clinical trials on zeolite as an anticancer agent have been published in the peer-reviewed literature.

5.8 Hemostasis

Diverse in vivo effects have been documented for clinoptilolite, including antioxidant, hemostatic, anti-diarrhetic, immunomodulatory, and detoxification properties. Zeolite-based hemostatic dressings (notably QuikClot, based on zeolite A or kaolin-impregnated gauze) have been used in emergency and military medicine to control hemorrhage, though these are distinct formulations from dietary supplement-grade clinoptilolite.

Evidence assessment: Hemostatic applications are evidence-based in the wound-care and surgical context for specific manufactured products, but are distinct from orally consumed dietary supplement forms. The evidence for oral zeolite affecting hemostasis systemically in humans is not established.

5.9 Bone Health

Clinoptilolite materials showed a number of positive effects on health, including antioxidative, immunostimulatory effects, antidiarrheal effects, positive effects on the bones, and anti-tumor effects, but usage in humans has not been comprehensively evaluated in large controlled clinical studies. Animal data suggest possible osteogenic effects, but no published controlled human clinical trials specifically on bone outcomes have been identified in the peer-reviewed literature.

6. Body Systems and Health Areas of Association

• Gastrointestinal tract: Antidiarrheal activity, intestinal barrier integrity (zonulin modulation), adsorption of intestinal toxins and mycotoxins, anti-diarrheal drug approval (Enterex)
• Detoxification / hepato-renal: Heavy metal binding and excretion (Pb, Cd, As, Hg, Ni, Cu, Cr), mobilization of toxicants from body compartments
• Immune system: Immunostimulatory and immunomodulatory effects on lymphocyte populations, proposed interactions with gut-associated lymphoid tissue
• Antioxidant defense: Upregulation of glutathione peroxidase, catalase, superoxide dismutase, and total antioxidant capacity, primarily demonstrated in animal models
• Oncology (preclinical only): Induction of tumor-suppressor proteins in cell lines; reduction of metastases in animal models; no human clinical trial data
• Bone: Suggested positive effects in animal and in vitro studies; human evidence absent
• Hemostasis (topical products): Evidence for topical zeolite dressings in wound care; systemic oral effects on hemostasis are not clinically established

7. Dosage Forms and Dosages Reported in Studies

The following dosages are reported directly from the cited clinical and preclinical research literature. They should not be interpreted as recommended therapeutic dosages.

• In a parallel-group immunodeficiency study, patients received daily TMAZ doses of 1.2 g (as Lycopenomin) and 3.6 g (as Megamin) for 6 to 8 weeks.
• In a randomized, double-blinded, placebo-controlled trial in aerobically trained subjects, 52 participants received 1.85 g of zeolite per day for 12 weeks.
• The dosage in a clinical trial on healthy subjects (MMBP) was adjusted according to PMA-zeolite certification and EFSA safety data. The explorative trial on healthy subjects lasted 28 days.
• In the long-term Frontiers in Medicine clinical trials, subjects received clinoptilolite for up to four years; the specific daily dose was calibrated according to EFSA safety recommendations for the material, though the precise daily gram quantity was not universally standardized across all trial arms.
• In a 90-day repeated-dose toxicity study in Sprague Dawley rats, the test substance was administered via oral gavage at doses of 0, 5, 10, and 15 mg/kg body weight per day, followed by a 28-day recovery period.

8. Safety Considerations

8.1 General Oral Safety

The basic structure of clinoptilolite is considered to be biologically neutral and non-toxic. Zeolite clinoptilolite has been proved to be safe, inert, and resilient to metabolism. Results from a 90-day toxicity study showed no adverse systemic, genotoxic, or irreversible effects at any dose tested. The highest dose tested (15 mg/kg/day) produced no adverse effects and was therefore identified as the no-observed-adverse-effect level (NOAEL). The NOAEL provides a substantial margin of safety; however, this should be interpreted as evidence of toxicological tolerance under the specific conditions of the study, rather than as definitive proof of broad human safety.

8.2 Regulatory Status

EFSA released an expert opinion on the safety of natural zeolite clinoptilolite in vivo and evaluated and confirmed the zeolite-clinoptilolite non-toxicity for animal feed at doses of 10,000 mg/kg. Oral consumption of this type of zeolite, due to its extreme chemical stability, in EFSA's opinion, does not represent a potential risk for in vivo applications. EFSA concluded that oral consumption of high-silica clinoptilolite does not pose a risk for applications in animal feed. The United States FDA has granted certain zeolites a Generally Recognized As Safe (GRAS) status, but this designation is specifically for technical uses, such as an anti-caking agent in animal feed. Clinoptilolite is classified as GRAS in the United States for use in animal feed and has regulatory approval as a medical device or supplement in the European Union.

The FDA has issued several warning letters to distributors for misleading claims about zeolite products.

8.3 Inhalation Hazard: Erionite vs. Clinoptilolite

A critical safety distinction concerns the difference between fibrous and non-fibrous zeolites: When fibrous erionite is aerosolized and inhaled, it has been linked to cases of lung cancers such as malignant mesothelioma. Fibrous erionite appears to be more carcinogenic than the six regulated asbestos minerals. The International Agency for Research on Cancer (IARC) has determined there is inadequate evidence in humans for the carcinogenicity of zeolites other than the naturally occurring erionite. IARC has found there is sufficient evidence that erionite is carcinogenic to humans and animals (Group 1); erionite causes mesothelioma. IARC also determined there is inadequate evidence in experimental animals for the carcinogenicity of natural zeolites specifically, including clinoptilolite, mordenite, phillipsite, and non-fibrous Japanese zeolite. Naturally occurring zeolites include those whose biological and chemical reactivity ranges from reportedly carcinogenic (erionite) to essentially non-toxic (clinoptilolite). Erionite's carcinogenic propensity derives from its asbestos-like fibrous structure.

Industrial exposure to inhaled zeolite dust is a known respiratory hazard, but the safety of ingested zeolite depends heavily on the specific grade and processing of the product.

8.4 Contaminant Risk in Raw Products

Vulkansandkuren, a zeolite product marketed in Europe, was found to contain high levels of heavy metals including arsenic, lead, mercury, cadmium, nickel, copper, and chromium. This underscores the importance of using adequately purified and tested clinoptilolite preparations for human consumption, and highlights that product quality is not uniform across commercially available supplements.

8.5 Gastrointestinal Effects and Mineral Interactions

Zeolites may cause local irritation and may alter the ionic composition, pH, and buffering capacity of the gastrointestinal tract under conditions of overexposure. Mineral and metal homeostasis in the organism underlies all biological processes, and eventual changes in this domain may be crucial in health outcomes. Long-term clinical monitoring data suggest that at studied doses, PMA-zeolite supplementation for up to four years did not produce clinically significant changes in essential mineral blood levels, although transient fluctuations were observed.

8.6 Potential Drug Interactions

Potential interactions include antibiotics, chemotherapy drugs, and immune-suppressing drugs. Zeolites may also interact with some chemotherapy drugs and make them less effective. The adsorptive capacity of clinoptilolite that underlies its proposed detoxifying effects is non-selective in principle, meaning it could theoretically bind to and reduce the bioavailability of co-administered pharmaceutical drugs if taken simultaneously. No large controlled human studies have specifically quantified this interaction for individual medications.

8.7 Gaps in Clinical Evidence

Clinoptilolite materials showed positive effects in animal models, but their usage in humans has not been comprehensively evaluated in detail within large controlled clinical studies. Accordingly, data on documented systemic effects on the human body are limited. Toxicology studies of this material are scarcely covered in the scientific literature. The systemic effects of natural zeolite-clinoptilolite are not well-understood, as its mechanism of action substantially differs from organic molecules such as those in pharmaceutical products or biotechnology-based medical products.

References

• Ivkovic S et al. Dietary supplementation with the tribomechanically activated zeolite clinoptilolite in immunodeficiency: effects on the immune system. Advances in Therapy, 2004 — PubMed
• Mastinu A et al. Critical Review on Zeolite Clinoptilolite Safety and Medical Applications in vivo. Molecules, 2019 — PMC
• Šimundić M et al. Clinical Evaluation of a Defined Zeolite-Clinoptilolite Supplementation Effect on the Selected Blood Parameters of Patients. Frontiers in Medicine, 2022 — PMC
• Tariba Lovaković B et al. The Impact of Long-Term Clinoptilolite Administration on the Concentration Profile of Metals in Rodent Organisms. Frontiers in Chemistry, 2023 — PMC
• Lamprecht M et al. Effects of zeolite supplementation on parameters of intestinal barrier integrity, inflammation, redoxbiology and performance in aerobically trained subjects. Journal of the International Society of Sports Nutrition, 2015 — PMC
• Zeolite and Neurodegenerative Diseases — PMC/NIH, 2024
• Selenium and Natural Zeolite Clinoptilolite Supplementation Increases Antioxidative Status and Immune Response in Growing Pigs — PMC, 2021
• In-field evaluation of clinoptilolite feeding efficacy on the reduction of milk aflatoxin M1 concentration in dairy cattle — PMC, 2016
• Zeolites as Ingredients of Medicinal Products — PMC/NIH, 2023
• Zeolites ameliorate asbestos toxicity in a transgenic model of malignant mesothelioma — PMC/NIH, 2020
• Safety Evaluation of Lab-Made Clinoptilolite: 90-Day Repeated Dose Toxicity Study. Toxics, 2026 — MDPI
• Clinical Evaluation of Zeolite-Clinoptilolite Supplementation. Frontiers in Medicine, 2022
• Global geological occurrence and character of the carcinogenic zeolite mineral, erionite. Frontiers in Chemistry, 2022
• Zeolite — Memorial Sloan Kettering Cancer Center Integrative Medicine
• Zeolites Statistics and Information — U.S. Geological Survey (USGS)
• Amended Safety Assessment of Zeolites as Used in Cosmetics — Cosmetic Ingredient Review (CIR), 2022
• Zeolite — New World Encyclopedia
• Pavelić K et al. Natural zeolite clinoptilolite: New adjuvant in anticancer therapy. Journal of Molecular Medicine, 2001 — ResearchGate
• What Is Zeolite Clinoptilolite? Uses and Safety — Biology Insights, 2026